December 19, 2013 at 11:44 AM EST
Alimera And pSivida Enter Label Talks

Alimera Sciences Inc. (Nasdaq: ALIM) and pSivida Corp. (Nasdaq: PSDV) entered labeling discussions with the Food and Drug Administration for their eye disease treatment Iluvien. Shares of Alimera leaped $1.53 to $4.08 while pSivida stock soared $1.12 to $4.09.


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here